Bioprinting of Synthetic Cell-like Lipid Vesicles to Augment the Functionality of Tissues after Manufacturing
ACS Synthetic Biology · 16.08.2024 · 13 (8) · 2436-2446
DOI: 10.1021/acssynbio.4c00137 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 18.07.2024. Verfasst von Ole Thaden und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioprinting & Tissue Engineering Group, Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg 69120, Germany. Hauptthemen laut MEDLINE: Bioprinting, Polyethylene Glycols, Unilamellar Liposomes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Studienstiftung des Deutschen Volkes.
Abstract (Originalsprache)
Bioprinting is an automated bioassembly method that enables the formation of human tissue-like constructs to restore or replace damaged tissues. Regardless of the employed bioprinting method, cells undergo mechanical stress that can impact their survival and function postprinting. In this study, we investigate the use of a synthetic cell-like unit, giant unilamellar vesicles (GUVs), as adjuvants of the cellular function of human cells postprinting, or in future as the complete replacement of human cells. We analyzed the impact of two nozzle-based bioprinting methods (drop-on-demand and extrusion bioprinting) on the structure, stability, and function of GUVs. We showed that over 65% of the GUVs remain intact when printing at 0.5 bar, demonstrating the potential of using GUVs as a synthetic cell source. We further increased the stability of GUVs in a cell culture medium by introducing polyethylene glycol (PEG) into the GUV lipid membrane. The presence of PEG, however, diminished the structural properties of GUVs postprinting, and reduced the interaction of GUVs with human cells. Although the design of PEG-GUVs can still be modified in future studies for better cell–GUV interactions, we demonstrated that GUVs are functional postprinting. Chlorin e6-PEG-GUVs loaded with a fluorescent dye were bioprinted, and they released the dye postprinting only upon illumination. This is a new strategy to deliver carriers, such as growth factors, drugs, nutrients, or gases, inside large bioprinted specimens on a millimeter to centimeter scale. Overall, we showed that printed GUVs can augment the functionality of manufactured human tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioprinting & Tissue Engineering Group, Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg 69120, Germany.
- Biophysical Engineering of Life Group, Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg 69120, Germany.
- Max Planck Institute for Medical Research, Heidelberg 69120, Germany.
ORCID-Profile: Kerstin Göpfrich, Daniela Duarte Campos
Förderung
- Deutsche Forschungsgemeinschaft
- Studienstiftung des Deutschen Volkes
Zitieren
APA
Thaden, O., Schneider, N., Walther, T., Spiller, E., Taoum, A., Göpfrich, K., & Duarte Campos, D. (2024). Bioprinting of Synthetic Cell-like Lipid Vesicles to Augment the Functionality of Tissues after Manufacturing. ACS Synthetic Biology, 13(8), 2436-2446. https://doi.org/10.1021/acssynbio.4c00137
Vancouver
Thaden O, Schneider N, Walther T, Spiller E, Taoum A, Göpfrich K, et al. Bioprinting of Synthetic Cell-like Lipid Vesicles to Augment the Functionality of Tissues after Manufacturing. ACS Synthetic Biology. 2024;13(8):2436-2446. doi:10.1021/acssynbio.4c00137
BibTeX
@article{Thaden2024,
author = {Thaden, Ole and Schneider, Nicole and Walther, Tobias and Spiller, Erin and Taoum, Alexandre and Göpfrich, Kerstin and Duarte Campos, Daniela},
title = {Bioprinting of Synthetic Cell-like Lipid Vesicles to Augment the Functionality of Tissues after Manufacturing},
journal = {ACS Synthetic Biology},
year = {2024},
volume = {13},
number = {8},
pages = {2436--2446},
doi = {10.1021/acssynbio.4c00137}
}
EUVIMED